Tag:
inflammation
Latest Headlines
Latest Headlines
GSK snags proteomics platform tech in $98M Cellzome buyout
GSK has opted to buy out the company for $98 million, snagging full rights to a pair of early-stage inflammation programs and a proteomics technology.
Weight loss cuts inflammation, cancer markers
Biomarker science published in Cancer Research shows that even losing a little weight cuts the inflammation, and so could cut the cancer risk.
Inflammatory protein marks heart disease
Heart disease has been linked with inflammation. Because signaling related to the protein biomarker interleukin-6 receptor (IL6R) can lead to inflammation, a team of researchers from the IL6R Genetics Consortium Emerging Risk Factors Collaboration looked at a genetic variant that affects this pathway to see if it was behind some aspects of the disease and could therefore also be a target for treatment and prevention.
With J&J deal undone, Orexo revamps drug delivery tech development
Sweden's Orexo will slash jobs and focus on three development programs that rely on enhancing already-approved treatments.
Cincinnati Children's debuts new anti-inflammatory drug class
After mixed attempts by others in the past, scientists at Cincinnati Children's Hospital Medical Center say they've developed a new class of compounds designed to prevent inflammation leading...
Human enzyme keeps mice thinner
A human enzyme helped boost the metabolism of mice and slowed their weight gain even with a high-fat diet, researchers from the Warren Alpert Medical School of Brown University, Rhode Island Hospital
Avaxia secures $2.2M for bowel treatment
Avaxia Biologics has nailed down $2.2 million in Series A venture financing to help launch a clinical trial for its inflammatory bowel disease drug next fall. The Lexington, MA-based company says the
Great minds collaborate on new RNAi approach to inflammation
A high profile team of scientists, including MIT's Robert Langer, investigators for Cambridge, MA-based Alnylam, as well as scientists from the Massachusetts General Hospital collaborated on a new
Quanterix tech helps measure Crohn's biomarkers
Quanterix, of Cambridge, MA, is touting its Single Molecule Array (SiMoA) technology in helping to measure inflammation biomarkers among patients with Crohn's disease. Crohn's is an inflammatory
BMS taps GNS Heathcare for computer model of inflammation
GNS Healthcare has bagged a deal with a major pharma. Bristol-Myers Squibb ($BMY) is working with the health analytics firm on a new computer model of immuno-inflammation, according to GNS. And the
